人福医药
(600079)
| 流通市值：287.65亿 | | | 总市值：304.25亿 |
| 流通股本：15.43亿 | | | 总股本：16.32亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 3,652,128,075.61 | 4,359,135,869.38 | 3,553,564,997.79 | 3,915,043,500.34 |
| 交易性金融资产 | 1,019,822,745.13 | 1,034,273,822.6 | 1,034,273,822.6 | 1,034,603,437.74 |
| 衍生金融资产 | 2,347,865.46 | 3,793,318.23 | 4,574,294.24 | 5,429,884.46 |
| 应收票据及应收账款 | 9,847,100,159.22 | 9,702,706,280.6 | 10,061,615,241.99 | 9,271,189,967.02 |
| 其中：应收票据 | 57,119,442.12 | 72,831,138.59 | 74,193,209.44 | 72,972,041.62 |
| 应收账款 | 9,789,980,717.1 | 9,629,875,142.01 | 9,987,422,032.55 | 9,198,217,925.4 |
| 应收款项融资 | 1,080,358,952.96 | 1,184,527,485.58 | 1,143,596,649.9 | 1,129,357,185.78 |
| 预付款项 | 473,723,164.21 | 419,092,844.52 | 455,517,353.63 | 407,818,094.24 |
| 其他应收款合计 | 286,562,999.18 | 339,255,941.26 | 419,192,534.63 | 283,124,705.48 |
| 应收股利 | - | 32,679,999.96 | - | - |
| 存货 | 3,471,284,412.06 | 3,441,167,421.16 | 3,483,780,612.13 | 3,566,397,534.27 |
| 其他流动资产 | 150,294,728.58 | 253,632,208.07 | 256,080,857.92 | 245,410,547.55 |
| 流动资产合计 | 19,983,623,102.41 | 20,737,585,191.4 | 20,412,196,364.83 | 19,858,374,856.88 |
| 非流动资产: | | | | |
| 长期应收款 | 280,524,606.31 | 296,820,606.31 | 336,784,606.31 | 336,784,606.31 |
| 长期股权投资 | 1,089,836,090.2 | 1,081,875,691.18 | 1,096,287,125.13 | 1,074,115,819.69 |
| 其他权益工具投资 | 851,649,302.31 | 801,409,412.25 | 707,540,143.98 | 741,914,805.6 |
| 固定资产 | 9,916,049,997.41 | 9,703,194,041.39 | 9,391,890,889.95 | 9,321,535,207.65 |
| 在建工程 | 808,713,689.06 | 882,892,985.91 | 1,205,376,366.04 | 1,267,849,250.12 |
| 使用权资产 | 76,390,087.15 | 81,819,173.71 | 93,243,404.78 | 99,329,350.88 |
| 无形资产 | 2,033,366,408.71 | 2,019,347,146.45 | 1,987,801,303.92 | 1,959,075,008.58 |
| 开发支出 | 623,191,027.91 | 639,281,987.65 | 673,192,913.53 | 659,243,958.76 |
| 商誉 | 687,662,371.65 | 729,078,058.07 | 729,124,526.53 | 729,148,709.1 |
| 长期待摊费用 | 49,380,724.62 | 52,525,262.03 | 24,799,693.01 | 26,165,509.35 |
| 递延所得税资产 | 92,677,316.6 | 94,311,510.68 | 92,753,836.85 | 92,762,671.4 |
| 其他非流动资产 | 331,122,305.78 | 434,993,954.38 | 415,554,871.79 | 342,024,227.43 |
| 非流动资产合计 | 16,840,563,927.71 | 16,817,549,830.01 | 16,754,349,681.82 | 16,649,949,124.87 |
| 资产总计 | 36,824,187,030.12 | 37,555,135,021.41 | 37,166,546,046.65 | 36,508,323,981.75 |
| 流动负债: | | | | |
| 短期借款 | 6,710,234,328.64 | 7,624,162,680.84 | 7,956,629,009.12 | 7,149,572,213.4 |
| 应付票据及应付账款 | 2,841,740,583.32 | 3,005,356,305.54 | 3,047,336,462.67 | 3,083,933,446.29 |
| 其中：应付票据 | 268,554,267.95 | 246,245,397.72 | 261,216,385.46 | 282,134,915.48 |
| 应付账款 | 2,573,186,315.37 | 2,759,110,907.82 | 2,786,120,077.21 | 2,801,798,530.81 |
| 预收款项 | 700,150.14 | 700,150.14 | 700,150.14 | 700,150.14 |
| 合同负债 | 355,915,515.65 | 324,811,890.87 | 325,719,780.05 | 341,605,133.34 |
| 应付职工薪酬 | 159,484,891.92 | 161,014,288.19 | 152,743,862.69 | 344,148,319.33 |
| 应交税费 | 362,145,126.86 | 292,197,920.17 | 318,883,388.39 | 335,919,224.49 |
| 其他应付款合计 | 1,106,838,448.89 | 1,440,349,792.94 | 1,136,072,426.64 | 1,183,146,150.39 |
| 应付股利 | 184,480,745.72 | 548,889,539.28 | 241,938,171.11 | 241,938,171.11 |
| 一年内到期的非流动负债 | 251,445,793.2 | 570,430,484.05 | 686,073,442.15 | 860,609,278.24 |
| 其他流动负债 | 42,350,251.32 | 39,372,198.14 | 39,839,267.96 | 40,342,306.32 |
| 流动负债合计 | 11,830,855,089.94 | 13,458,395,710.88 | 13,663,997,789.81 | 13,339,976,221.94 |
| 非流动负债: | | | | |
| 长期借款 | 1,863,528,227.98 | 1,426,710,473.91 | 890,053,551.24 | 1,191,687,462.38 |
| 租赁负债 | 55,934,523.47 | 60,312,739.29 | 67,058,537.43 | 72,533,309.36 |
| 长期应付款 | 16,000,000 | 16,000,000 | 16,000,000 | 16,000,000 |
| 递延收益 | 773,340,436.17 | 788,712,703.03 | 793,474,057.57 | 790,525,089.52 |
| 递延所得税负债 | 383,759,546.28 | 398,458,713.86 | 399,497,729.43 | 404,542,912.05 |
| 非流动负债合计 | 3,092,562,733.9 | 2,690,194,630.09 | 2,166,083,875.67 | 2,475,288,773.31 |
| 负债合计 | 14,923,417,823.84 | 16,148,590,340.97 | 15,830,081,665.48 | 15,815,264,995.25 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,632,225,965 | 1,632,225,965 | 1,632,225,965 | 1,632,225,965 |
| 资本公积 | 5,685,064,721.91 | 5,684,298,344.61 | 5,684,298,344.61 | 5,684,298,344.61 |
| 其他综合收益 | 249,322,227.09 | 205,301,931.99 | 96,841,642.55 | 126,430,409.81 |
| 盈余公积 | 592,578,811.67 | 592,578,811.67 | 592,578,811.67 | 592,578,811.67 |
| 未分配利润 | 10,754,549,544.69 | 10,220,639,760.86 | 10,128,630,807.38 | 9,588,285,347.99 |
| 归属于母公司股东权益合计 | 18,913,741,270.36 | 18,335,044,814.13 | 18,134,575,571.21 | 17,623,818,879.08 |
| 少数股东权益 | 2,987,027,935.92 | 3,071,499,866.31 | 3,201,888,809.96 | 3,069,240,107.42 |
| 股东权益合计 | 21,900,769,206.28 | 21,406,544,680.44 | 21,336,464,381.17 | 20,693,058,986.5 |
| 负债和股东权益合计 | 36,824,187,030.12 | 37,555,135,021.41 | 37,166,546,046.65 | 36,508,323,981.75 |
| 公告日期 | 2025-10-30 | 2025-08-28 | 2025-04-29 | 2025-04-29 |
| 审计意见(境内) | | | | 带强调事项段的无保留意见 |